These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24940066)

  • 61. Pharmacist Adscription To Intensive Care: Generating Synergies.
    Franco Sereno MT; Pérez Serrano R; Ortiz Díaz-Miguel R; Espinosa González MC; Abdel-Hadi Álvarez H; Ambrós Checa A; Rodríguez Martínez M
    Med Intensiva (Engl Ed); 2018 Dec; 42(9):534-540. PubMed ID: 29605582
    [TBL] [Abstract][Full Text] [Related]  

  • 62. D-dimer Is a Predictor of 28-Day Mortality in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
    Lu J; Wang X; Chen Q; Chen M; Cheng L; Jiang H; Sun Z
    Arch Med Res; 2016 Jul; 47(5):356-364. PubMed ID: 27751369
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CRRT technology and logistics: is there a role for a medical emergency team in CRRT?
    Honoré PM; Joannes-Boyau O; Gressens B
    Contrib Nephrol; 2007; 156():354-64. PubMed ID: 17464146
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The impact of clinical pharmacist in a cardiac-surgery intensive care unit.
    Al-Jazairi AS; Al-Agil AA; Asiri YA; Al-Kholi TA; Akhras NS; Horanieh BK
    Saudi Med J; 2008 Feb; 29(2):277-81. PubMed ID: 18246241
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Predictive value of RIFLE classification on prognosis of critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
    Li WX; Chen HD; Wang XW; Zhao S; Chen XK; Zheng Y; Song Y
    Chin Med J (Engl); 2009 May; 122(9):1020-5. PubMed ID: 19493435
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
    Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy.
    Trotman RL; Williamson JC; Shoemaker DM; Salzer WL
    Clin Infect Dis; 2005 Oct; 41(8):1159-66. PubMed ID: 16163635
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Considerations for Medication Management and Anticoagulation During Continuous Renal Replacement Therapy.
    Thompson A; Li F; Gross AK
    AACN Adv Crit Care; 2017; 28(1):51-63. PubMed ID: 28254856
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Current state of continuous renal replacement therapy for acute kidney injury in Japanese intensive care units in 2011: analysis of a national administrative database.
    Iwagami M; Yasunaga H; Noiri E; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Nangaku M; Doi K
    Nephrol Dial Transplant; 2015 Jun; 30(6):988-95. PubMed ID: 25795153
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Preparation times and costs for various solutions used for continuous renal replacement therapy.
    Shaw AR; Chaijamorn W; Clark JS; Mueller BA
    Am J Health Syst Pharm; 2018 Jun; 75(11):808-815. PubMed ID: 29802114
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Outcome of continuous renal replacement therapy in critically ill children: a retrospective cohort study.
    Al-Ayed T; Rahman NU; Alturki A; Aljofan F
    Ann Saudi Med; 2018; 38(4):260-268. PubMed ID: 30078024
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of a clinical pharmacist in a multidisciplinary intensive care unit.
    Montazeri M; Cook DJ
    Crit Care Med; 1994 Jun; 22(6):1044-8. PubMed ID: 8205814
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Case Report: Therapeutic Drug Monitoring of Polymyxin B During Continuous Renal Replacement Therapy in Two Pediatric Patients: Do Not Underestimate Extracorporeal Clearance.
    Xu C; Liu X; Cui Y; Huang X; Wang Y; Fan Y; Wu H; Li X; Guo B; Zhang J; Zhang Y
    Front Pharmacol; 2022; 13():822981. PubMed ID: 35401193
    [No Abstract]   [Full Text] [Related]  

  • 74. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry.
    Sutherland SM; Zappitelli M; Alexander SR; Chua AN; Brophy PD; Bunchman TE; Hackbarth R; Somers MJ; Baum M; Symons JM; Flores FX; Benfield M; Askenazi D; Chand D; Fortenberry JD; Mahan JD; McBryde K; Blowey D; Goldstein SL
    Am J Kidney Dis; 2010 Feb; 55(2):316-25. PubMed ID: 20042260
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vancomycin therapy in critically ill patients on continuous renal replacement therapy; are we doing enough?
    Omrani AS; Mously A; Cabaluna MP; Kawas J; Albarrak MM; Alfahad WA
    Saudi Pharm J; 2015 Jul; 23(3):327-9. PubMed ID: 26106281
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dynamic dosing for continuous renal replacement therapy: Service evaluation of the safety and effectiveness of titrating dose to biochemistry.
    Eldridge JC; Bhardwaj Shah A; Lucena-Amaro S; Kirwan CJ; Prowle JR; Wan YI
    J Intensive Care Soc; 2024 Feb; 25(1):50-58. PubMed ID: 39323594
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Availability of information for dosing commonly used medications in special ICU populations.
    Eastman C; Erstad BL
    Am J Health Syst Pharm; 2020 Mar; 77(7):529-534. PubMed ID: 32207817
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The benefit of specialized team approaches in patients with acute kidney injury undergoing continuous renal replacement therapy: propensity score matched analysis.
    Oh HJ; Lee MJ; Kim CH; Kim DY; Lee HS; Park JT; Na S; Han SH; Kang SW; Koh SO; Yoo TH
    Crit Care; 2014 Aug; 18(4):454. PubMed ID: 25116900
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effectiveness of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: a propensity score-matched analysis.
    Zhai XB; Gu ZC; Liu XY
    Ther Clin Risk Manag; 2016; 12():241-50. PubMed ID: 26937196
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.